Foresite Capital Management V, Acquires 140,000 Shares of Latigo Biotherapeutics (NASDAQ:LTGO) Stock August 11, 2026 by InsiderTrades.com Share Key Points Foresite Capital Management V purchased 140,000 Latigo Biotherapeutics shares at $18.00 each, for a total investment of $2.52 million. Following the transaction, Foresite owned 2,008,024 shares valued at approximately $36.14 million, representing a 7.49% increase in its ownership. Latigo shares opened at $18.56, compared with a 52-week range of $17.22 to $22.47. The purchase was disclosed in an SEC filing. Latigo Biotherapeutics, Inc. (NASDAQ:LTGO - Get Free Report) major shareholder Foresite Capital Management V, purchased 140,000 shares of the firm's stock in a transaction that occurred on Monday, August 10th. The stock was acquired at an average price of $18.00 per share, with a total value of $2,520,000.00. Following the completion of the purchase, the insider owned 2,008,024 shares in the company, valued at $36,144,432. This represents a 7.49% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Large shareholders that own at least 10% of a company's shares are required to disclose their transactions with the SEC.Latigo Biotherapeutics Price PerformanceShares of NASDAQ LTGO opened at $18.56 on Tuesday. Latigo Biotherapeutics, Inc. has a 1 year low of $17.22 and a 1 year high of $22.47. See AlsoFive stocks we like better than Latigo BiotherapeuticsSoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat3 Dividend Champion Utilities for a Market That Can't Sit StillThese 3 Most-Upgraded Stocks Have Almost Nothing to Do With AIFirst Solar’s Profit Engine Faces a New Policy Test in WashingtonThis instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected]. Insider Buying or Selling at Latigo Biotherapeutics? Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Latigo Biotherapeutics and related companies. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | Sponsored Free Insider Buying and Selling Newsletter Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | Sponsored Most Read This MonthInsiders Sell, Institutions Buy: The AI Trade Is Getting More InterestingTSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?Insiders Sell 2 AI Enablers: Investors Can Buy Into Their FuturesInsider Moves Are Sending Mixed Signals Across the Tech SectorInsider Selling: Planet Labs PBC (NYSE:PL) Director Sells $169,883.04 in StockInsider Buying: Lumen Technologies (NYSE:LUMN) CEO Acquires $613,000.00 in StockGlen Alexander Milne Acquires 138,500 Shares of Inventus Mining (CVE:IVS) StockAshley Johnson Sells 75,035 Shares of Planet Labs PBC (NYSE:PL) StockRecent ArticlesFrancis Felber Buys 500 Shares of Citizens Community Bancorp (NASDAQ:CZWI) StockChe-Chia Wei Acquires 152 Shares of Taiwan Semiconductor Manufacturing (NYSE:TSM) StockJason Keyes Purchases 700 Shares of BlossomHill Therapeutics (NASDAQ:BLSM) StockWatt Foster, Jr. Buys 447 Shares of Bank of the James Financial Group (NASDAQ:BOTJ) StockCornelius Prior, Jr. Sells 500 Shares of ATN International (NASDAQ:ATNI) StockMichael Dean Brown Sells 200 Shares of Travel + Leisure (NYSE:TNL) StockInsider Buying: Mackenzie Realty Capital (NASDAQ:MKZR) General Counsel Buys $15,900.00 in StockInsider Selling: GlobalFoundries (NASDAQ:GFS) Insider Sells $16,177.15 in Stock
